Skip to main content
SpringerLink
Log in

Somatic mutations of calreticulin in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumors of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 75–86

    Google Scholar 

  2. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379–2390

    Article  CAS  PubMed  Google Scholar 

  3. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D et al (2014) Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123:2645–2651

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Barraco D, Lasho TL, Gangat N, Finke C, Elala YC, Pardanani A et al (2016) Leukocytosis and presence of CALR mutation is associated with non-hepatosplenicextramedullary hematopoiesis in primary myelofibrosis. Blood Cancer J 6:e436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Orazi A, Germing U (2008) The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 22:1308–1319

    Article  CAS  PubMed  Google Scholar 

  7. DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC et al (2014) Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history andclinical outcome by treatment strategy. Leukemia 28:958–961

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, 34 Zhongshan North Road, Quanzhou, Fujian Province, China

    Xueya Zhang & Jingxin Pan

Authors
  1. Xueya Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingxin Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xueya Zhang.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

This research work was supported by Foundation of Fujian Educational Committee (JA15198).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Pan, J. Somatic mutations of calreticulin in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable. Ann Hematol 96, 1949–1951 (2017). https://doi.org/10.1007/s00277-017-3100-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3100-0

Search

Navigation